Okupe Oluyemi 4

What Happened

• Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), exercised stock options to acquire a total of 12,553 shares (5,553 shares at $5.01 for $27,821; 7,000 shares at $11.53 for $80,710) and sold 19,645 shares in an open-market transaction on April 20, 2026 for aggregate proceeds of about $588,615 (weighted average price $29.96). The filing reports both the option-to-share conversions (derivative activity) and the subsequent sale of shares the same day.

Key Details

• Transaction date: April 20, 2026 (Form 4 filed April 22, 2026 — timely filing).
• Option exercises (code M): 5,553 shares @ $5.01 (acquired $27,821); 7,000 shares @ $11.53 (acquired $80,710).
• Open-market sale (code S): 19,645 shares @ weighted avg $29.96 (range $29.95–$30.005) — proceeds ≈ $588,615. The filer will provide per-price breakdown upon request (footnote F2).
• Additional derivative entries at $0.00 reflect the conversion/termination of the derivative instruments upon exercise (reported as dispositions of the derivative).
• Footnotes: trades were executed under a Rule 10b5-1 trading plan adopted May 21, 2025 (F1); options noted as fully vested and exercisable (F3) and subject to a 4‑year service-based vesting schedule with monthly vesting starting April 1, 2023 (F4).
• Shares owned after the transaction: not specified in the provided filing details.

Context

• The filing shows an exercise of options and same-day sale of shares, a common pattern when insiders exercise vested options and sell stock (often to cover exercise costs, taxes, or per a pre-established trading plan). These transactions were conducted under a 10b5-1 plan, which establishes the sales were prearranged rather than opportunistic. This report is factual and does not imply insider motivation.